Pharmacology and Toxicology
Student Name: Christopher Adanty
Supervisor: Dr. Vincenzo De Luca
Christopher graduated with an Honours Bachelor of Science with high distinction in June 2019. He completed a double specialist in Pharmacology and Biomedical Toxicology.
Christopher has been the recipient of numerous awards and scholarships recognizing his academic and extracurricular achievements. For his academic achievements Christopher was awarded the President’s Entrance Scholarship, multiple Chancellor’s Scholarships from Trinity College, the Provost W.T Delworth Graduation Award and the Pharmacology Fellowship scholarship.
After completing his third year of undergraduate studies, Christopher participated in the Professional Experience Year (PEY) program offered by the Department of Pharmacology and Toxicology. Christopher was subsequently selected to complete a co-op position at Sanofi Pasteur – a world renowned pharmaceutical company. While working as an analyst at Sanofi Pasteur, Christopher attained valuable pharmaceutical research experience conducting small-scale vaccine-formulation experiments. Additionally, while completing an Honor’s thesis project under Dr. Lisa Robinson, Christopher utilized numerous in-vitro molecular biology techniques when probing the therapeutic potential of neuronal guidance cue Slit2’s ability to inhibit monocyte migration.
In addition to his academic and research commitments, Christopher served as the Director of Communications (2016-2017) and Co-President (2018-2019) of the Pharmacology and Toxicology Students Association. In recognition of his leadership in student governance during his undergraduate degree, Christopher was awarded the Graduate & Life Sciences Education Undergraduate Student Leadership Award. Moreover, as the current Communications Officer for the Black Graduate Students Association, Christopher is highly dedicated to serving the needs of Black Canadian students. Outside of school Christopher enjoys reading and writing about geopolitical conflicts that interest him.
Christopher is currently working towards an MSc in Pharmacology as a member of Dr. Vincenzo De Luca’s lab at the Centre for Addiction and Mental Health (CAMH). Under the guidance of clinician-scientist Dr. De Luca, Christopher is exploring the dynamic epigenetic and neuroimaging changes predictive of suicidal behaviour in schizophrenia patients. The ultimate goal of Christopher’s research is to identify novel epigenetic and neuroimaging biomarkers predictive of suicidal behaviour in patients with schizophrenia.